BioCryst Pharmaceuticals, Inc. logo BCRX - BioCryst Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 25
HOLD 4
SELL 0
STRONG
SELL 0
| PRICE TARGET: $16.86 DETAILS
HIGH: $25.00
LOW: $8.00
MEDIAN: $15.00
CONSENSUS: $16.86
UPSIDE: 103.38%

Profitability Ratios

Ratio Value
GP Margin 97.8%
EBIT Margin 39.6%
EBITDA Margin 39.7%
Operating Margin 39.0%
Pretax Margin 30.6%
Cont. Ops Margin 30.2%
Net Margin 30.2%
Bottom Line Margin 30.2%

Liquidity Ratios

Ratio Value
Current Ratio 2.06
Quick Ratio 2.03
Solvency Ratio 0.419
Cash Ratio 0.46

Valuation Ratios

Ratio Value
Price/Earnings
6.20
Hist. avg: 6.2
Peers avg: 54.7
PEG Ratio -0.02
Forward PEG -0.02
Price/Book -13.74
Price/Sales 1.87
Price/FCF 5.00
Price/Op Cash Flow 4.96

Debt Ratios

Ratio Value
Debt/Assets 0.9284
Debt/Equity -4.0060
Debt/Capital 1.3327
Long-Term Debt/Capital 1.3868
Financial Leverage -4.32

Cash Flow Ratios

Ratio Value
Working Capital Turnover 3.72
Operating Cash Flow Ratio 1.682
Operating Cash Flow/Sales 37.7%
Free Cash Flow/Operating Cash Flow 99.3%

Coverage Ratios

Ratio Value
Debt Service Coverage 2.89
Interest Coverage 4.3233
Short-Term Operating Cash Flow Coverage 8.23
Operating Cash Flow Coverage 0.69
Capital Expenditure Coverage 133.66
Dividend + Capital Expenditure Coverage 133.66

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 4.17
EPS 1.257
Debt/Share 2.6499
Cash/Share 1.31
Book Value/Share -0.57
Tangible BV/Share -0.57
Equity/Share -0.57
Operating Cash Flow/Share 1.572
Capital Expenditure/Share 0.012
FCF/Share 1.560

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.987
Earnings Before Tax/EBIT 0.784
Price/Fair Value -13.74
Debt/Market Cap 0.2854
Effective Tax Rate 1.3%
Enterprise Value Multiple 5.82